Year |
Citation |
Score |
2019 |
Santoro A, Vlachou T, Luzi L, Melloni G, Mazzarella L, D'Elia E, Aobuli X, Pasi CE, Reavie L, Bonetti P, Punzi S, Casoli L, Sabò A, Moroni MC, Dellino GI, et al. p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value. Cell Reports. 26: 624-638.e8. PMID 30650356 DOI: 10.1016/j.celrep.2018.12.071 |
0.309 |
|
2015 |
Koren S, Reavie L, Couto JP, De Silva D, Stadler MB, Roloff T, Britschgi A, Eichlisberger T, Kohler H, Aina O, Cardiff RD, Bentires-Alj M. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature. 525: 114-8. PMID 26266975 DOI: 10.1038/nature14669 |
0.336 |
|
2015 |
Danielson LS, Reavie L, Coussens M, Davalos V, Castillo-Martin M, Guijarro MV, Coffre M, Cordon-Cardo C, Aifantis I, Ibrahim S, Liu C, Koralov SB, Hernando E. Limited miR-17-92 overexpression drives hematologic malignancies. Leukemia Research. 39: 335-41. PMID 25597017 DOI: 10.1016/J.Leukres.2014.12.002 |
0.465 |
|
2013 |
King B, Trimarchi T, Reavie L, Xu L, Mullenders J, Ntziachristos P, Aranda-Orgilles B, Perez-Garcia A, Shi J, Vakoc C, Sandy P, Shen SS, Ferrando A, Aifantis I. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell. 153: 1552-66. PMID 23791182 DOI: 10.1016/J.Cell.2013.05.041 |
0.591 |
|
2013 |
Reavie L, Buckley SM, Loizou E, Takeishi S, Aranda-Orgilles B, Ndiaye-Lobry D, Abdel-Wahab O, Ibrahim S, Nakayama KI, Aifantis I. Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell. 23: 362-75. PMID 23518350 DOI: 10.1016/J.Ccr.2013.01.025 |
0.565 |
|
2012 |
Verga Falzacappa MV, Ronchini C, Reavie LB, Pelicci PG. Regulation of self-renewal in normal and cancer stem cells. The Febs Journal. 279: 3559-72. PMID 22846222 DOI: 10.1111/j.1742-4658.2012.08727.x |
0.325 |
|
2012 |
Moran-Crusio K, Reavie LB, Aifantis I. Regulation of hematopoietic stem cell fate by the ubiquitin proteasome system. Trends in Immunology. 33: 357-63. PMID 22349458 DOI: 10.1016/J.It.2012.01.009 |
0.576 |
|
2011 |
Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, Figueroa ME, Vasanthakumar A, Patel J, Zhao X, Perna F, Pandey S, Madzo J, Song C, Dai Q, et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell. 20: 11-24. PMID 21723200 DOI: 10.1016/J.Ccr.2011.06.001 |
0.546 |
|
2010 |
Crusio KM, King B, Reavie LB, Aifantis I. The ubiquitous nature of cancer: the role of the SCF(Fbw7) complex in development and transformation. Oncogene. 29: 4865-73. PMID 20543859 DOI: 10.1038/Onc.2010.222 |
0.487 |
|
2010 |
Reavie L, Della Gatta G, Crusio K, Aranda-Orgilles B, Buckley SM, Thompson B, Lee E, Gao J, Bredemeyer AL, Helmink BA, Zavadil J, Sleckman BP, Palomero T, Ferrando A, Aifantis I. Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex. Nature Immunology. 11: 207-15. PMID 20081848 DOI: 10.1038/Ni.1839 |
0.573 |
|
2009 |
Buonamici S, Trimarchi T, Ruocco MG, Reavie L, Cathelin S, Mar BG, Klinakis A, Lukyanov Y, Tseng JC, Sen F, Gehrie E, Li M, Newcomb E, Zavadil J, Meruelo D, et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature. 459: 1000-4. PMID 19536265 DOI: 10.1038/Nature08020 |
0.554 |
|
2009 |
Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proceedings of the National Academy of Sciences of the United States of America. 106: 1814-9. PMID 19188590 DOI: 10.1073/Pnas.0808263106 |
0.37 |
|
2008 |
Buonamici S, Trimarchi T, Klinakis A, Reavie L, Mar BG, Gehrie E, Kuan EL, Randolph GJ, Bromberg J, Aifantis I. Knockdown of CCR7 or Its Ligands Causes a Loss of Central Nervous System Involvement in Notch1 Induced T-ALL Blood. 112: 199-199. DOI: 10.1182/Blood.V112.11.199.199 |
0.563 |
|
Show low-probability matches. |